| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |